What's New in Rare Gynecologic Cancers: 2023 Updates

Learn what’s new in the treatment of rare gynecologic cancers, as presented by Dr. Amanda Nickles-Fader, ‪@JohnsHopkinsMedicine‬ and the Sidney Kimmel Cancer Center.

[@NurseQuipy]

Is the anticipated response to immunotherapy for clear cell subtype only for the very small percentage of clear cells that are MSH? With LOH greater than 16%? Or is the hope that many women with clear cell who are MSS with lower LOH scores also likely to respond? Is A TMB score of 4 ok?